Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin

BACKGROUND: Protein arginine methyltransferase 5 (PRMT5), a type II PRMT, is highly expressed in some tumors, but its role in hepatocellular carcinoma (HCC) is still unknown. METHODS: PRMT5 level in HCC specimens was determined by immunohistochemical staining and the association with clinicopatholog...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Baolai, Dong, Shuhong, Li, Zhongxin, Lu, Li, Zhang, Su, Chen, Xue, Cen, Xiaobo, Wu, Yongjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635578/
https://www.ncbi.nlm.nih.gov/pubmed/26541651
http://dx.doi.org/10.1186/s12967-015-0721-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635578/
https://www.ncbi.nlm.nih.gov/pubmed/26541651
http://dx.doi.org/10.1186/s12967-015-0721-8

Ejemplares similares